Invention Grant
- Patent Title: HIV vaccine immunogens
-
Application No.: US17299852Application Date: 2019-11-27
-
Publication No.: US12239698B2Publication Date: 2025-03-04
- Inventor: Michel Nussenzweig , Pamela J. Bjorkman , Amelia Escolano , Harry Gristick
- Applicant: The Rockefeller University , California Institute of Technology
- Applicant Address: US NY New York; US CA Pasadena
- Assignee: The Rockefeller University,California Institute of Technology
- Current Assignee: The Rockefeller University,California Institute of Technology
- Current Assignee Address: US NY New York; US CA Pasadena
- Agency: Fox Rothschild LLP
- International Application: PCT/US2019/063619 WO 20191127
- International Announcement: WO2020/117590 WO 20200611
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61P31/18 ; C07K14/005 ; A61K39/00
Abstract:
This disclosure provides HIV immunogens and use thereof for generating an immune response in a subject. Also disclosed is a method of isolating anti-HIV antibodies and use thereof. This disclosure further provides a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject using the disclosed HIV immunogens and/or antibodies.
Public/Granted literature
- US20220031830A1 HIV VACCINE IMMUNOGENS Public/Granted day:2022-02-03
Information query
